View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
HOVON 132 AML / SAKK 30/13 - B - Idarubicin 12 / Cytarabine 200 / Lenalidomide 20, induction, Acute Myeloid Leukemia, cycle 1
Protocol-ID: 1065 V1.1 (Mini), STUDY-HOVON 132 AML / SAKK 30/13 - B - IDAR12/CYTA200/LENA20, Ind., AML, C1Indication(s)
- Acute Myeloid Leukemia; ICD-10 C92.0-, C92.5-, C93.0-, C92.8-, C92.6-, C92.7-, C92.9-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 02.04.2021